Founded in 2015 by Cambridge University graduates Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is about more than just technology. We're on a mission to improve people's quality of life with neural engineering. We envision a future where our Neural Digital Therapy technology is being used to give back control, over our bodies and lives, enabling radically improved, seamlessly experienced healthcare.

Decades ago, DNA sequencing opened up a new field of precision medicine. Now, AI is doing the same for the nervous system and BIOS is at the forefront, building the infrastructure on which future neural treatments will be discovered, developed, and delivered. ​

The brain sends our bodies vast amounts of information every second of every day, but when those signals are faulty it can cause our organs and systems to malfunction, causing disease. BIOS has developed neural interfaces and AI that, for the first time, can read and write the body’s neural data, or ‘code’, to understand and correct those signals in real-time. ​

BIOS envisions a new field of digital health treatments that use this new data-driven insight from the nervous system to create better, more targeted medicine. Neural digital therapies will use our read/write software to understand the effects on the nerves, leading to more precise creation of pharmaceuticals and software-delivered treatments direct to the nervous system.

With our proprietary neural interface and AI platform, BIOS has the unique ability to measure and analyse neural data in real-time in both acute and chronic settings.

BIOS has developed a programming language or 'code' for the nervous system that can be used for discovering groundbreaking insights into diseases, and creating new treatments.

Neural digital therapeutics are created by using real-time feedback from the nervous system. This makes better, more targeted drugs, and opens the door for software-delivered therapies.

We envision a future where we have control over our bodies and lives, enabling radically improved, seamlessly experienced healthcare. We want a better quality of life for everyone living with lifelong conditions.

Your response to a therapy is as unique as your DNA. BIOS’s Neural Dosing Platform combines high-quality neural recordings with powerful AI and ML techniques to personalise neural therapies in minutes.

Cardiovascular diseases are responsible for a third of all deaths globally. BIOS has launched the Autonomic Therapy Initiative (ATI) to discover more about the causal links with the nervous system and to drive forward neural therapies and treatments that could help millions of people.

BIOS' technology is capable of real-time insights into how pharmaceuticals affect the nervous system, cutting feedback time on efficacy results from months to minutes. We offer long-term partnerships for the co-development of neural digital therapies.